logo
Select company
Select metric
Ticker Information

Ticker

IMNN

Company Name

IMUNON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMUNON INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMNN - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 294.77K0%$ 0
3/31/2025$ 277.44K0%$ 0
12/31/2024$ 29.54K0%$ 0
9/30/2024$ 14.63K0%$ 0
6/30/2024$ 252.1K0%$ 0
3/31/2024$ 406.37K0%$ 0
12/31/2023$ 451.76K0%$ 0
9/30/2023$ 496.67K397.33%$ 125K
6/30/2023$ 313.19K125.28%$ 250K
3/31/2023$ 269.05K71.75%$ 375K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMUNON INC's latest trailing twelve months (TTM) CapEx % stands at 5.33%.
  • Over the past 5 years, IMUNON INC's average CapEx % has been 76.92%.
  • The median CapEx % for IMUNON INC during this period was 50.13%
  • IMUNON INC reached its highest CapEx % over the past 5 years at 397.33%.
  • The lowest CapEx % recorded by IMUNON INC in the same timeframe 3.82%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for IMUNON INC is calculated as follows: CapEx [ $ 26.63K ] / Revenues [ $ 500K ]
(=) CapEx % [ 5.33% ]

IMNN - Capital Expenditures Margin, Last 5 years

3.82%

Minimum

Dec 31, 2020

397.33%

Maximum

Sep 30, 2023

76.92%

Average

50.13%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.02%
average3.47%
median2.43%
std3.27%